AnsellFRA:PD1 76 EV-to-FCF is 16.78 as of Jun. 30, 2026, which is 14% below its 10-year median of 19.60. GuruFocus rates FRA:PD1 with a GF Score™ of 76/100 and a GF Value™ of €63.91. The stock has 4 warning signs investors should review. Among 419 Medical Devices & Instruments companies, Ansell ranks better than 64.2% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Ansell's Enterprise Value is €2,998 Mil.
Ansell's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €179 Mil. Therefore, Ansell's EV-to-FCF for today is 16.78.
The historical rank and industry rank for Ansell's EV-to-FCF or its related term are showing as below:
FRA:PD1'
s EV-to-FCF Range Over the Past 10 Years
Min: 10.33 Med: 19.6 Max: 49.16
Current: 16.9
During the past 13 years, the highest EV-to-FCF of Ansell was 49.16. The lowest was 10.33. And the median was 19.60.
FRA:PD1's EV-to-FCF is ranked better than 64.2% of 419
companies
in the Medical Devices & Instruments industry
Industry Median: 22.57
vs FRA:PD1: 16.90
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-06-30), Ansell's stock price is €69.00.
Ansell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €3.194. Therefore, Ansell's PE Ratio (TTM) for today is 21.60.
Ansell (FRA:PD1) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ansell's share price for today is €69.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ansell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €3.194.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Ansell EV-to-FCF Related Terms
Ansell EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Ansell's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Ansell's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ansell EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ansell's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Ansell's EV-to-FCF falls into.
Ansell's current Enterprise Value is €2,998 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ansell's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €179 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ansell (FRA:PD1) has a EV-to-FCF of 16.78 as of Jun. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Ansell and its competitors. This is 14% below median its historical median of 19.60. Over the past decade, Ansell's EV-to-FCF has ranged from 10.33 to 49.16. According to the industry distribution chart, Ansell ranks #150 out of 419 companies in the Medical Devices & Instruments industry, placing it in the top 35.8%.
Is Ansell's EV-to-FCF too high?
Ansell's current EV-to-FCF of 16.78 is 14% below median its 10-year median of 19.60. Over the past 10 years, this metric has ranged from a low of 10.33 to a high of 49.16. The Medical Devices & Instruments industry median EV-to-FCF is 22.57. Ansell's value of 16.78 is 25.7% below this industry median. Based on the distribution chart, Ansell ranks #150 out of 419 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ansell has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Ansell's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ansell ranks #150 out of 419 companies for EV-to-FCF. This puts Ansell in the upper half of its industry. The industry median EV-to-FCF is 22.57. Ansell's value of 16.78 is 25.7% below this benchmark. Historically, Ansell's own EV-to-FCF has ranged from 10.33 to 49.16 over the past decade. While the company's 10-year median is 19.60 vs. the industry median of 22.57, Ansell has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.57, based on 419 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ansell's current EV-to-FCF of 16.78 is 25.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Ansell and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ansell's current EV-to-FCF is 16.78, which is 14% below median its own 10-year median of 19.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ansell stock overvalued right now?
Ansell (FRA:PD1) has a current EV-to-FCF of 16.78. The stock's GF Value™ is €63.91, compared to a current price of €69.00 — trading 8% above its estimated fair value. The current EV-to-FCF is 16.78, which is 14% below median its 10-year median of 19.60 and 25.7% below the Medical Devices & Instruments industry median of 22.57. Ansell's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Ansell (FRA:PD1), the current EV-to-FCF is 16.78 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ansell (FRA:PD1) Overvalued in 2026?
Based on GuruFocus' analysis, Ansell stock appears to be overvalued.
The current stock price of €69.00 is trading 8% above its estimated GF Value™ of €63.91.
Key valuation signals for FRA:PD1:
EV-to-FCF: 16.78 (14% below median its 10-year median of 19.60)
GF Value™: €63.91 vs. price of €69.00 (8% above fair value)
Industry Position: 25.7% below the Medical Devices & Instruments median (#150 of 419)
No single metric tells the full story. See the FRA:PD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 55% of revenue and operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents, and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly. Largest sales regions are North America and Europe, Middle East, and Africa. Asia-Pacific and Latin America, combined, are about one-fourth of sales.
76GF Score
Get the complete analysis for FRA:PD1
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PD1 has been successfully added to your 
